Cardinal Health enters $4.0 billion unsecured revolving credit facility through 2031
Cardinal Health signed a $4.0 billion unsecured revolving credit agreement running through August 7, 2031, and terminated its existing $2.0 billion five-year and $1.0 billion 364-day credit facilities plus a $1.0 billion receivables sale program. The new facility replaces those arrangements and is intended for general corporate purposes. The filing reports no termination penalties and a financial covenant requiring a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00.
Key points
- New $4.0 billion revolving credit facility matures August 7, 2031, with an option to extend by up to two years subject to conditions
- Terminated $2.0 billion five-year credit agreement dated February 27, 2023 and $1.0 billion 364-day credit agreement dated October 7, 2025
- Terminated $1.0 billion receivables sale program; the filing states no penalties were incurred
- Financial covenant requires Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00 at each fiscal quarter end
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.